Pharma-Giant Partnerships: Collaborations Between Biotechs and Multinationals Supercharge Natural Killer Cell Therapeutics Development
The natural killer (NK) cell therapeutics market is witnessing a wave of partnerships between established pharmaceutical giants and agile biotech firms, bridging innovation gaps and accelerating commercialization. Multinationals like Novartis and Pfizer, with deep R&D and global distribution networks, are teaming up with biotechs (e.g., Allogene, Lyell Immunopharma) that possess...
0 Comments
0 Shares
443 Views
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek